Neural Regeneration Research ›› 2023, Vol. 18 ›› Issue (9): 1954-1955.doi: 10.4103/1673-5374.367845
Previous Articles Next Articles
Oriana Mandolfo, Brian W. Bigger*
Online:
Published:
Contact:
Supported by:
Abstract: Lysosomal storage diseases: Lysosomal storage diseases (LSDs) are a family of about 70 disorders, with an overall incidence of 1:7000 live births. They are caused by dysfunctional lysosomal hydrolases, eventually leading to the accumulation of undegraded substrate into the lysosome. This results in a wide array of symptoms, which may include: the presence of dysmorphic features, cardio-respiratory disease, bone and joint disease, organomegaly, developmental delay and neurocognitive decline. The majority of these diseases have a neurological component and in the absence of treatment, death often occurs in the first decades of life, with the neurological complications drastically undermining the patient’s quality of life, as well as their families (Boustany, 2013).
Oriana Mandolfo, Brian W. Bigger. Gene-modified neural progenitor cells for the treatment of neuropathic lysosomal storage diseases[J]. Neural Regeneration Research, 2023, 18(9): 1954-1955.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.sjzsyj.com.cn/EN/10.4103/1673-5374.367845
https://www.sjzsyj.com.cn/EN/Y2023/V18/I9/1954